April 4, 2022
Not intended for U.S. and UK Media – Late-Breaking Data from prespecified subgroup analyses of prespecified pooled analysis FIDELITY presented at the American College of Cardiology’s (ACC) 71st Annual Scientific Session (ACC.22)
New data for finerenone on the risk reduction of cardiovascular and renal outcomes in patients with a combination of atherosclerotic cardiovascular disease, chronic kidney disease and type 2 diabetes